[1]梁道博,姚卜飞,夏双燕.氯吡格雷联合阿司匹林治疗急性冠脉综合征疗效与 安全性的Meta分析[J].医学信息,2019,32(11):76-80.[doi:10.3969/j.issn.1006-1959.2019.11.021]
　LIANG Dao-bo,YAO Bu-fei,XIA Shuang-yan.Meta-analysis of the Efficacy and Safety of Clopidogrel Combined with Aspirin in the Treatment of Acute Coronary Syndrome[J].Journal of Medical Information,2019,32(11):76-80.[doi:10.3969/j.issn.1006-1959.2019.11.021]
点击复制

氯吡格雷联合阿司匹林治疗急性冠脉综合征疗效与 安全性的Meta分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年11期
页码:
76-80
栏目:
论著
出版日期:
2019-06-01

文章信息/Info

Title:
Meta-analysis of the Efficacy and Safety of Clopidogrel Combined with Aspirin in the Treatment of Acute Coronary Syndrome
文章编号:
1006-1959（2019）11-0076-05
作者:
梁道博; 姚卜飞; 夏双燕
山西医科大学，山西 晋中 030600
Author(s):
LIANG Dao-bo; YAO Bu-fei; XIA Shuang-yan
Shanxi Medical University,Jinzhong 030600,Shanxi,China
关键词:
急性冠脉综合征; 氯吡格雷; 阿司匹林; Meta分析
Keywords:
Key words：Acute coronary syndrome; Clopidogrel; Aspirin; Meta-analysis
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2019.11.021
文献标志码:
A
摘要:
目的 系统评价氯吡格雷联合阿司匹林治疗急性冠脉综合征的疗效。方法 计算机检索英文数据库Embase、Pubmed、The Cochrane Library以及中文数据库CBM、CNKI和WanFang Data，搜集有关氯吡格雷联合阿司匹林治疗急性冠脉综合征的相关临床研究，且研究必须为随机对照试验（RCT）。检索时限从2008年1月~2019年1月。由三位评价员独立筛选文献、提取资料并评价纳入的各项临床研究之间的偏移风险[Tau2=0.00；Chi2=3.35；df=10（P=0.97）；I2=0]后，运用RevMan 5.3软件进行Meta分析。结果 最终纳入11项临床研究，包括2518名患者。Meta分析结果显示：与单用阿司匹林相比，氯吡格雷联合阿司匹林能明显提高治疗的有效率[OR=3.12,95%CI（2.20,4.42）,P<0.00001]，其中部分研究报道了氯吡格雷联合 阿司匹林治疗急性冠脉综合征的同时，肌钙蛋白的含量出现了降低[OR=4.94,95%CI（1.77,13.79）,P=0.002]；对报道中的不良反应（包括心血管事件的发生、血小板的降低、出血等）进行分析，差异无统计学意义（P＞0.05）。结论 氯吡格雷联合阿司匹林能提高对患有急性冠脉综合征的患者的疗效，并且可能不增加不良反应的发生率。由于受纳入的临床研究质量的限制，上述结论还需通过更多的质量更高的研究予以验证。
Abstract:
Abstract：Objective To evaluate the efficacy of clopidogrel combined with aspirin in the treatment of acute coronary syndrome.Methods We searched the English database Embase, Pubmed, The Cochrane Library and Chinese database CBM, CNKI and WanFang Data, collect relevant clinical studies related to clopidogrel plus aspirin treatment of acute coronary syndrome, and studies must be randomized controlled trials (RCT). The search time limit is from January 2008 to January 2019. Three reviewers independently screened the literature, extracted the data, and evaluated the risk of migration between the included clinical studies [Tau2=0.00; Chi2=3.35; df=10 (P=0.97); I2=0] Meta analysis was performed using RevMan 5.3 software.Results Finally,11 clinical studies were included, including 2,518 patients. Meta-analysis showed that clopidogrel combined with aspirin significantly improved the efficacy of treatment compared with aspirin alone [OR=3.12, 95% CI (2.20, 4.42),P<0.00001], some of which reported chloropyrryl While germination combined with aspirin in the treatment of acute coronary syndrome, troponin content was reduced [OR=4.94, 95% CI (1.77, 13.79),P=0.002]; adverse reactions reported (including cardiovascular events) The occurrence, thrombocytopenia, hemorrhage, etc. were analyzed,the difference was not statistically significant (P>0.05).Conclusion Clopidogrel combined with aspirin can improve the efficacy of patients with acute coronary syndrome and may not increase the incidence of adverse reactions. Due to the limitations of the quality of the included clinical studies, the above conclusions need to be verified by more quality studies.

参考文献/References:

[1]Kheiri B,Abdalla A,Osman M.Personalized antiplatelet therapy in patients with coronary artery disease undergoing percutaneous coronary intervention:A network meta-analysis of randomized clinical trials[J].Catheter Cardiovasc Interv,2019. [2]Wang D,Yang XH,Zhang JD,et al.Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome:a meta-analysis[J].BMC Cardiovasc Disord,2018,18(1):217. [3]王知军.急性冠脉综合征的治疗综述[J].中国乡村医药,2008(5):52-53. [4]杜绮钧.晚期糖基化终产物对急性冠脉综合征血小板活性的影响及其机制[D].复旦大学,2013. [5]陈平钰,马爱霞.急性冠脉综合征药物干预策略经济学评析综述[J].中国药物评价,2014,31(3):189-192. [6]Higgins JP,Altman DG,Gotzsche PC,et al.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials[J].BMJ,2011,343(7829):889-893. [7]陈亮.阿司匹林联合氯吡格雷在急性冠脉综合征中的疗效观察[J].现代诊断与治疗,2013,24(11):2473-2474. [8]代春伟.氯吡格雷合阿司匹林治疗急性冠脉综合征的疗效[J].实用中西医结合临床,2018,18(1):70-71. [9]蔡德印.氯吡格雷联合阿司匹林在急性冠脉综合征中的应用效果观察[J].中国实用医药,2013,8(17):133. [10]谭威政.氯吡格雷联合阿司匹林治疗急性冠脉综合征的临床观察[J].中国社区医师(医学专业),2011,13(20):44. [11]张亚玲.氯吡格雷联合阿司匹林治疗急性冠脉综合征的临床价值[J].中国药物经济学,2014,9(4):72-73. [12]邵恩浓.氯吡格雷联合阿司匹林治疗急性冠脉综合征疗效分析[J].中西医结合心血管病电子杂志,2018,6(14):45,48. [13]汪爱民,朱世瑶,李金能,等.氯吡格雷联合阿司匹林治疗急性冠脉综合征疗效观察[J].西部医学,2013,25(3):395-396. [14]谢强旺.氯吡格雷联合阿司匹林治疗急性冠脉综合征临床观察[J].中国现代药物应用,2012,6(16):66-67. [15]石俊松.氯吡格雷联合阿司匹林治疗急性冠脉综合征临床疗效评价[J].九江学院学报(自然科学版),2014,29(3):83-84, 120. [16]李全亮.氯吡格雷联合阿司匹林治疗急性冠脉综合征探讨[J].中外医疗,2015,34(35):107-108. [17]孙文科.氯吡格雷与拜阿斯匹林联合治疗急性冠脉综合征的疗效及安全性评价[J].临床医学研究与实践,2017,2(26):18-19.

相似文献/References:

[1]赵殿儒,祁景蕊.不同剂量瑞舒伐他汀对急性冠脉综合征患者心功能和炎症因子的影响[J].医学信息,2019,32(01):148.[doi:10.3969/j.issn.1006-1959.2019.01.046]
　ZHAO Dian-ru,YAN Jing-rui.Effects of Different Doses of Rosuvastatin on Cardiac Function and Inflammatory Factors in Patients with Acute Coronary Syndrome[J].Journal of Medical Information,2019,32(11):148.[doi:10.3969/j.issn.1006-1959.2019.01.046]
[2]镡子鸣,叶怀阔,任长杰.超敏C反应蛋白及妊娠相关血浆蛋白A预测再发急性冠脉综合征的临床价值[J].医学信息,2019,32(08):173.[doi:10.3969/j.issn.1006-1959.2019.08.055]
　TAN Zi-ming,YE Huai-kuo,et al.Clinical Value of High-sensitivity C-reactive Protein and Pregnancy-associated Plasma Protein A in Predicting Recurrent Acute Coronary Syndrome[J].Journal of Medical Information,2019,32(11):173.[doi:10.3969/j.issn.1006-1959.2019.08.055]
[3]张牧秋,古俊楠,刘 瑜,等.NOACS治疗房颤合并急性冠脉综合征的研究[J].医学信息,2019,32(13):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
　ZHANG Mu-qiu,GU Jun-nan,LIU Yu,et al.Study of NOACS in the Treatment of Atrial Fibrillation Complicated with Acute Coronary Syndrome[J].Journal of Medical Information,2019,32(11):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
[4]王建强,刘 瑜,张牧秋,等.房颤伴ACS患者经皮冠状动脉介入术后抗栓研究[J].医学信息,2019,32(14):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
　WANG Jian-qiang,LIU Yu,ZHANG Mu-qiu,et al.Study on Antithrombotic after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and ACS[J].Journal of Medical Information,2019,32(11):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
[5]王 焕.替格瑞洛在氯吡格雷抵抗AMI患者PCI术后抗血小板治疗中的应用[J].医学信息,2019,32(24):153.[doi:10.3969/j.issn.1006-1959.2019.24.055]
　WANG Huan.Application of Ticagrelor in the Antiplatelet Therapy of Clopidogrel in Patients with AMI after PCI[J].Journal of Medical Information,2019,32(11):153.[doi:10.3969/j.issn.1006-1959.2019.24.055]
[6]孙 洋,高 山,宋 京,等.血尿酸、同型半胱氨酸、脑钠肽、肌钙蛋白Ⅰ与急性冠脉综合征病变程度的相关性[J].医学信息,2020,33(02):105.[doi:10.3969/j.issn.1006-1959.2020.02.028]
　SUN Yang,GAO Shan,SONG Jing,et al.Correlation Between Serum Uric Acid,Homocysteine,Brain Natriuretic Peptide,TroponinⅠ and the Severity of Acute Coronary Syndrome[J].Journal of Medical Information,2020,33(11):105.[doi:10.3969/j.issn.1006-1959.2020.02.028]
[7]史作霞,张文彦,李 馨,等.改良桡动脉止血器在老年ACS患者动脉穿刺后压迫止血中的效果[J].医学信息,2020,33(02):184.[doi:10.3969/j.issn.1006-1959.2020.02.060]
　SHI Zuo-xia,ZHANG Wen-yan,LI Xin,et al.Evaluation of Improved Radial Arterial Hemostatic Device in Compression Hemostasis After Arterial Puncture in Elderly Patients with ACS[J].Journal of Medical Information,2020,33(11):184.[doi:10.3969/j.issn.1006-1959.2020.02.060]
[8]刘廷胜.氯吡格雷联合阿司匹林治疗急性心肌梗死的研究[J].医学信息,2020,33(06):59.[doi:10.3969/j.issn.1006-1959.2020.06.018]
　LIU Ting-sheng.A Study of Clopidogrel Combined with Aspirin in the Treatment of Acute Myocardial Infarction[J].Journal of Medical Information,2020,33(11):59.[doi:10.3969/j.issn.1006-1959.2020.06.018]
[9]栾学冰.拜阿斯匹林、那曲肝素联合氯吡格雷治疗急性ST段抬高型心肌梗死疗效[J].医学信息,2020,33(09):136.[doi:10.3969/j.issn.1006-1959.2020.09.043]
　LUAN Xue-bing.The Efficacy of Bayaspirin,Naltreparin Combined with Clopidogrel in the Treatment of Acute ST-segment Elevation Myocardial Infarction[J].Journal of Medical Information,2020,33(11):136.[doi:10.3969/j.issn.1006-1959.2020.09.043]
[10]刘 楠.阿司匹林联合氯吡格雷双抗血小板治疗脑梗死的疗效观察及对血清hs-CRP及D-D水平的影响[J].医学信息,2022,35(19):82.[doi:10.3969/j.issn.1006-1959.2022.19.022]
　LIU Nan.The Effect of Aspirin Combined with Clopidogrel Dual Antiplatelet Therapy on Cerebral Infarction and its Effect on Serum hs-CRP and D-D Levels[J].Journal of Medical Information,2022,35(11):82.[doi:10.3969/j.issn.1006-1959.2022.19.022]

更新日期/Last Update: 2019-06-01